Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
01 1FARMAK, A.S.
02 2Veranova, L.P.
03 1Apicore US LLC
04 1Aurobindo Pharma Limited
05 1Enaltec Labs Pvt Ltd
06 2Industriale Chimica s.r.l.
07 1MSN Life Sciences Private Limited
08 1Sionc Pharmaceutical Private Limited
01 3DOFETILIDE
02 7Dofetilide
01 1Czech Republic
02 5India
03 2Italy
04 2U.S.A
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
NDC Package Code : 63278-1079
Start Marketing Date : 2000-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Veranova: A CDMO that manages complexity with confidence.
NDC Package Code : 49812-0261
Start Marketing Date : 2014-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Veranova: A CDMO that manages complexity with confidence.
NDC Package Code : 50137-4245
Start Marketing Date : 2016-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14096-192
Start Marketing Date : 2013-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-038
Start Marketing Date : 2023-12-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42413-0170
Start Marketing Date : 2018-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63190-0670
Start Marketing Date : 1999-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63190-0680
Start Marketing Date : 1999-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69766-022
Start Marketing Date : 2016-12-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76055-0013
Start Marketing Date : 2019-12-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Dofetilide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dofetilide, including repackagers and relabelers. The FDA regulates Dofetilide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dofetilide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dofetilide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dofetilide supplier is an individual or a company that provides Dofetilide active pharmaceutical ingredient (API) or Dofetilide finished formulations upon request. The Dofetilide suppliers may include Dofetilide API manufacturers, exporters, distributors and traders.
click here to find a list of Dofetilide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dofetilide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dofetilide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dofetilide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dofetilide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dofetilide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dofetilide suppliers with NDC on PharmaCompass.
We have 8 companies offering Dofetilide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
